Stock QTXB QUANTRX BIOMEDICAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News QuantRx Biomedical Corporation

Equities

QTXB

US74765N1090

Market Closed - OTC Markets
Other stock markets
 01:37:42 2024-02-26 pm EST 		5-day change 1st Jan Change
0.004 USD -.--% Intraday chart for QuantRx Biomedical Corporation -.--% -49.37%
2022 QuantRx Biomedical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
2022 Michael Abrams Resigns as a Member of the Board of Directors of QuantRx Biomedical Corporation CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
QUANTRX BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
QuantRx Biomedical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
QuantRx Biomedical : Management Change/Compensation - Form 8-K
PU
Michael Abrams Resigns as a Member of the Board of Directors of QuantRx Biomedical Corporation
CI
QUANTRX BIOMEDICAL CORP : Change in Directors or Principal Officers (form 8-K)
AQ
QUANTRX BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
QuantRx Biomedical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
QUANTRX BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
QuantRx Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
QUANTRX BIOMEDICAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
QuantRx Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2021
CI
QuantRx Biomedical Corporation Auditor Raises 'Going Concern' Doubt
CI
QUANTRX BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
QuantRx Biomedical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
QUANTRX BIOMEDICAL : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
Quantrx Biomedical Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
QUANTRX BIOMEDICAL : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
Quantrx Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
QUANTRX BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
Quantrx Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. QTXB Stock
  4. News QuantRx Biomedical Corporation